The development of therapeutic antibodies against dengue virus

Antiviral Research
Guntur Fibriansah, Shee-Mei Lok

Abstract

Dengue virus, a positive-sense RNA virus, is one of the major human pathogens transmitted by mosquitoes. However, no fully effective licensed dengue vaccines or therapeutics are currently available. Several potent neutralizing antibodies against DENV have been isolated from mice and humans, and the characterization of their properties by biochemical and biophysical methods have revealed important insights for development of therapeutic antibodies. In this review, we summarize recently reported antibody-antigen complex structures, their likely neutralization mechanisms and enhancement propensities, as well as their prophylactic and therapeutic capabilities in mouse models. This article forms part of a symposium on flavivirus drug discovery in the journal Antiviral Research.

References

Oct 1, 1987·Microbial Pathogenesis·D M MorensN J Marchette
Aug 1, 1997·Nature Medicine·J R PutnakB L Innis
Jun 11, 1999·Journal of Biotechnology·P ThullierJ C Mazié
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P Hilgard, R Stockert
Apr 12, 2003·The Journal of Experimental Medicine·Boonrat TassaneetrithepMary A Marovich
May 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yorgo ModisStephen C Harrison
Jan 23, 2004·Nature·Yorgo ModisStephen C Harrison
Apr 27, 2005·Nature Medicine·Theodore OliphantMichael S Diamond
Sep 30, 2005·Nature·Grant E NybakkenDaved H Fremont
Aug 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bärbel KaufmannMichael G Rossmann
Nov 18, 2006·Nature Immunology·Matthew J RobinsonCaetano Reis e Sousa
Feb 16, 2007·Journal of Virology·Manoj N KrishnanErol Fikrig
May 23, 2007·Archives of Virology·S A Reading, N J Dimmock
Dec 27, 2007·Viral Immunology·Allison ImriePaul Effler
Feb 12, 2008·Nature Structural & Molecular Biology·Shee-Mei LokMichael G Rossmann
Apr 19, 2008·Nature Reviews. Immunology·Greg Lemke, Carla V Rothlin
Dec 20, 2008·PLoS Pathogens·Hilde M van der SchaarJolanda M Smit
Sep 16, 2009·Annals of the New York Academy of Sciences·Katherine L WilliamsEva Harris
Dec 4, 2009·PLoS Pathogens·Bärbel KaufmannMichael G Rossmann
Jul 2, 2010·Journal of Virology·Soila Sukupolvi-PettyMichael S Diamond
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bärbel KaufmannMichael G Rossmann
May 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Andrew S KondratowiczWendy Maury
May 25, 2011·The Journal of Infectious Diseases·Wanwisa DejnirattisaiGavin Screaton

❮ Previous
Next ❯

Citations

Mar 12, 2016·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Samson Sai-Yin WongSally Cheuk-Ying Wong
Jun 11, 2016·Current Opinion in Virology·Yu-Chih Lo, Guey Chuen Perng
Aug 11, 2016·Journal of Medical Virology·Ying-Shan HanMark A Wainberg
Sep 27, 2016·Antiviral Research·Mariano A Garcia-BlancoChristopher Nicchitta
Mar 30, 2017·Antimicrobial Agents and Chemotherapy·Juan-Carlos Saiz, Miguel A Martín-Acebes
Feb 8, 2018·Scientific Reports·Kittima AmornwachirabodeeSupason Wanichwecharungruang
Aug 11, 2019·Current Pharmaceutical Biotechnology·Miriam DiboLígia C Faccin-Galhardi
Feb 27, 2020·Reviews in Medical Virology·Arianna Mahely Hurtado-MonzónRosa María Del Ángel
Sep 16, 2017·PLoS Pathogens·Denise HaslwanterKarin Stiasny
Jun 3, 2020·Transactions of the Royal Society of Tropical Medicine and Hygiene·Ruta KulkarniVidya A Arankalle
Dec 22, 2017·NPJ Vaccines·Georgina SalazarZhiqiang An
Feb 6, 2020·PLoS Neglected Tropical Diseases·Stefan MalafaKarin Stiasny
Oct 20, 2018·Nature Immunology·Jose Luis Slon CamposGavin R Screaton
Oct 17, 2019·Frontiers in Immunology·Lorrany Dos Santos FrancoJaime Henrique Amorim
Apr 2, 2019·Nucleosides, Nucleotides & Nucleic Acids·Ayman M S AhmedAbdalla E A Hassan
Apr 2, 2020·Applied Microbiology and Biotechnology·Abhishek Singh RathoreRinkoo Devi Gupta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Antiviral Research
Kitti Wing Ki ChanSubhash G Vasudevan
Viral Immunology
David L Woodland
Critical Reviews in Immunology
Huda Makhluf, Sujan Shresta
© 2022 Meta ULC. All rights reserved